TrialRespiratory research2019

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.

Frank C Albers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.